N -Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR  ≥ 30 ml/min/1.73 m 2

ConclusionAcSDKP represents a potentially useful biomarker to predict alterations in the renal function of patients with diabetes presenting normoalbuminuria.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research